Biotech · Private company
RemeGen Co., Ltd.
Track this companyFree. Adds RemeGen Co., Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- Telitacicept 160mgPhase 2 · IgA NephropathyClinicalTrials.gov · fetched Nov 12, 2026
- Telitacicept 240mgPhase 2 · IgA NephropathyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid TumorsPHASE2 · ACTIVE_NOT_RECRUITING · started May 20, 2024ClinicalTrials.gov NCT06157892 · fetched Nov 12, 2026
- Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2PHASE3 · ACTIVE_NOT_RECRUITING · started Sep 22, 2023ClinicalTrials.gov NCT05911295 · fetched Nov 12, 2026
- A Study of Telitacicept for Injection (RC18) in Subjects With IgA NephropathyPHASE2 · TERMINATED · started Nov 4, 2021ClinicalTrials.gov NCT04905212 · fetched Nov 12, 2026